Search results
Results From The WOW.Com Content Network
It is published by Elsevier and the editor-in-chief is Marianna Kruithof-de Julio (University of Bern) The Gene Family of journals comprises the journals Gene, Gene Reports, Human Gene, and Plant Gene. According to the Journal Citation Reports, the journal has a 2022 impact factor of 3.5. [1]
The Journal of Gene Medicine is a monthly peer-reviewed medical ... the journal has a 2020 impact factor of 4 ... This page was last edited on 12 September 2024, ...
Cambiogenplasmid (Neovasculgen): treatment for vascular endothelial growth factor peripheral artery disease Ciltacabtagene autoleucel (Carvykti): treatment for multiple myeloma [ 6 ] Delandistrogene moxeparvovec (Elevidys): treatment for Duchenne muscular dystrophy [ 7 ] [ 8 ]
The gene therapy will compete with Australia-based CSL Behring’s Hemgenix, a similar treatment that won FDA approval for hemophilia B in 2022. That drug has a similar list price of $3.5 million ...
2024 could bring more effective ways to treat Alzheimer’s, schizophrenia, and hemophilia.
This list of over 500 monoclonal antibodies includes approved and investigational drugs as well as drugs that have been withdrawn from market; consequently, the column Use does not necessarily indicate clinical usage. See the list of FDA-approved therapeutic monoclonal antibodies in the monoclonal antibody therapy page.
Medical journals are published regularly to communicate new research to clinicians, medical scientists, and other healthcare workers. This article lists academic journals that focus on the practice of medicine or any medical specialty. Journals are listed alphabetically by journal name, and also grouped by the subfield of medicine they focus on.
In combination with palbociclib and fulvestrant for the treatment of adults with endocrine-resistant, PIK3CA-mutated, hormone receptor (HR)-positive, human epidermal growth-factor receptor 2 (HER2)-negative, locally advanced or metastatic breast cancer, as detected by an FDA-approved test, following recurrence on or after completing adjuvant ...